BRCA1 - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of its breast cancer therapy, Keytruda.

Hormonal contraceptives and breast cancer risk in BRCA1 carriers

HQ Team January 17, 2025: A study has found a significant association between the use of hormonal contraceptives and an increased risk of.

by HealthQuill
January 17, 2025
0 Comments

Uncategorized

Elevated β-hCG linked to BRCA1 mutations in breast cancer

Bharti Jayshankar December 16, 2024: Researchers at the Rajiv Gandhi Biotechnology Centre, Kerala, delving into the molecular mechanisms of tumorigenesis by BRCA1 gene,.

by HealthQuill
December 16, 2024
0 Comments

About Us

Contact Info

Follow Us

Hormonal contraceptives and breast cancer risk in BRCA1 carriers

Elevated β-hCG linked to BRCA1 mutations in breast cancer